RWJ-37947

N/A

Report date: 2023/11/10 15:44:32
NME

Base Information

Drug NameRWJ-37947
Drug Alias NameRWJ-37947
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A